| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.852 | 0.003 | 0.852 | Bronchodilator | 0.795 0.003 DBMET03357 | ||
| 0.838 | 0.004 | 0.838 | Antiadrenergic | 0.776 0.004 DBMET03357 | ||
| 0.836 | 0.004 | 0.836 | Adrenaline antagonist | 0.774 0.004 DBMET03357 | ||
| 0.83 | 0.004 | 0.843 | Spasmolytic | 0.843 0.004 DBMET03357 | DBMET03357 | |
| 0.777 | 0.006 | 0.777 | Antiobesity | 0.64 0.016 DBMET03357 | ||
| 0.662 | 0.005 | 0.662 | Psychostimulant | 0.627 0.005 DBMET03357 | ||
| 0.658 | 0.004 | 0.658 | Calcium channel L-type activator | 0.633 0.004 DBMET03357 | ||
| 0.665 | 0.011 | 0.665 | Toll-Like receptor 7 agonist | 0.617 0.015 DBMET03357 | ||
| 0.658 | 0.005 | 0.746 | Vasodilator, coronary | 0.746 0.004 DBMET03357 | DBMET03357 | |
| 0.661 | 0.011 | 0.661 | Toll-Like receptor agonist | 0.614 0.015 DBMET03357 | ||
| 0.651 | 0.01 | 0.674 | Vasodilator, peripheral | 0.674 0.008 DBMET03357 | DBMET03357 | |
| 0.628 | 0.002 | 0.628 | Phenylalanine 4-hydroxylase inhibitor | 0.338 0.004 DBMET03357 | ||
| 0.64 | 0.021 | 0.64 | Cyclophilin D inhibitor | 0.529 0.042 DBMET03357 | ||
| 0.582 | 0.005 | 0.582 | Peroxidase inhibitor | 0.49 0.01 DBMET03357 | ||
| 0.593 | 0.02 | 0.612 | Aldehyde oxidase inhibitor | 0.612 0.017 DBMET03357 | DBMET03357 | |
| 0.574 | 0.017 | 0.595 | 5 Hydroxytryptamine release stimulant | 0.595 0.015 DBMET03357 | DBMET03357 | |
| 0.55 | 0.002 | 0.575 | Beta adrenoreceptor antagonist | 0.575 0.002 DBMET03357 | DBMET03357 | |
| 0.581 | 0.034 | 0.629 | Transcription factor NF kappa B inhibitor | 0.629 0.028 DBMET03357 | DBMET03357 | |
| 0.536 | 0.002 | 0.536 | Adrenaline agonist | 0.474 0.002 DBMET03357 | ||
| 0.535 | 0.004 | 0.535 | Anesthetic local | 0.516 0.004 DBMET03357 | ||
| 0.539 | 0.012 | 0.539 | Cardiotonic | 0.494 0.016 DBMET03357 | ||
| 0.522 | 0.004 | 0.522 | 5 Hydroxytryptamine uptake stimulant | 0.512 0.004 DBMET03357 | ||
| 0.515 | 0.008 | 0.515 | Interleukin agonist | 0.468 0.011 DBMET03357 | ||
| 0.501 | 0.002 | 0.501 | Beta 2 adrenoreceptor antagonist | 0.466 0.002 DBMET03357 | ||
| 0.483 | 0.016 | 0.546 | Hypoxia-inducible factor 1 alpha inhibitor | 0.546 0.011 DBMET03357 | DBMET03357 | |
| 0.477 | 0.014 | 0.477 | Vasodilator | 0.45 0.016 DBMET03357 | ||
| 0.449 | 0.002 | 0.458 | Beta 1 adrenoreceptor antagonist | 0.458 0.002 DBMET03357 | DBMET03357 | |
| 0.441 | 0.002 | 0.441 | Beta 3 adrenoreceptor antagonist | 0.426 0.002 DBMET03357 | ||
| 0.46 | 0.039 | 0.46 | Cholesterol antagonist | 0.416 0.046 DBMET03357 | ||
| 0.408 | 0.015 | 0.408 | Sodium/bile acid cotransporter inhibitor | 0.399 0.017 DBMET03357 | ||
| 0.393 | 0.002 | 0.393 | Beta adrenoreceptor agonist | 0.281 0.002 DBMET03357 | ||
| 0.404 | 0.016 | 0.443 | Cyclic AMP phosphodiesterase inhibitor | 0.443 0.011 DBMET03357 | DBMET03357 | |
| 0.395 | 0.009 | 0.395 | Tyrosine 3 hydroxylase inhibitor | 0.336 0.019 DBMET03357 | ||
| 0.44 | 0.056 | 0.44 | 5 Hydroxytryptamine release inhibitor | 0.42 0.066 DBMET03357 | ||
| 0.433 | 0.058 | 0.433 | Histamine release inhibitor | 0.398 0.077 DBMET03357 | ||
| 0.397 | 0.026 | 0.442 | Calcium channel activator | 0.442 0.013 DBMET03357 | DBMET03357 | |
| 0.356 | 0.002 | 0.356 | Adenylate cyclase stimulant | 0.331 0.002 DBMET03357 | ||
| 0.4 | 0.049 | 0.4 | Antithrombotic | 0.371 0.057 DBMET03357 | ||
| 0.407 | 0.058 | 0.407 | Calpain 2 inhibitor | 0.361 0.081 DBMET03357 | ||
| 0.355 | 0.011 | 0.355 | Peptidyltransferase inhibitor | 0.326 0.017 DBMET03357 | ||
| 0.352 | 0.009 | 0.352 | Adenylate cyclase inhibitor | 0.273 0.017 DBMET03357 | ||
| 0.338 | 0.009 | 0.338 | Acetylcholine M1 receptor antagonist | 0.282 0.018 DBMET03357 | ||
| 0.362 | 0.034 | 0.424 | Superoxide dismutase inhibitor | 0.424 0.023 DBMET03357 | DBMET03357 | |
| 0.425 | 0.097 | 0.505 | Caspase 9 stimulant | 0.505 0.058 DBMET03357 | DBMET03357 | |
| 0.334 | 0.013 | 0.334 | Alpha-N-acetylglucosaminidase inhibitor | 0.172 0.044 DBMET03357 | ||
| 0.322 | 0.007 | 0.322 | Nitric-oxide synthase stimulant | 0.321 0.007 DBMET03357 | ||
| 0.355 | 0.045 | 0.362 | Antioxidant | 0.362 0.043 DBMET03357 | DBMET03357 | |
| 0.313 | 0.008 | 0.313 | Acetylcholine muscarinic antagonist | 0.252 0.014 DBMET03357 | ||
| 0.313 | 0.011 | 0.313 | M18 aspartyl aminopeptidase inhibitor | 0.278 0.016 DBMET03357 | ||
| 0.342 | 0.041 | 0.36 | Free radical scavenger | 0.36 0.036 DBMET03357 | DBMET03357 | |
| 0.341 | 0.04 | 0.341 | Hypoglycemic | 0.306 0.051 DBMET03357 | ||
| 0.295 | 0.009 | 0.371 | Expectorant | 0.371 0.005 DBMET03357 | DBMET03357 | |
| 0.302 | 0.015 | 0.302 | Insulin sensitizer | 0.278 0.022 DBMET03357 | ||
| 0.301 | 0.014 | 0.301 | Cholinergic antagonist | 0.239 0.023 DBMET03357 | ||
| 0.285 | 0.005 | 0.285 | Alpha adrenoreceptor agonist | 0.281 0.005 DBMET03357 | ||
| 0.292 | 0.014 | 0.292 | Acetylcholine antagonist | 0.234 0.023 DBMET03357 | ||
| 0.277 | 0.004 | 0.277 | Glutamate decarboxylase inhibitor | 0.178 0.009 DBMET03357 | ||
| 0.274 | 0.005 | 0.329 | Mucolytic | 0.329 0.004 DBMET03357 | DBMET03357 | |
| 0.27 | 0.002 | 0.27 | Beta 1 adrenoreceptor agonist | 0.179 0.002 DBMET03357 | ||
| 0.266 | 0.002 | 0.266 | Beta 2 adrenoreceptor agonist | 0.206 0.002 DBMET03357 | ||
| 0.323 | 0.059 | 0.323 | Interleukin 2 agonist | 0.269 0.099 DBMET03357 | ||
| 0.333 | 0.069 | 0.333 | Immunostimulant | 0.273 0.088 DBMET03357 | ||
| 0.287 | 0.037 | 0.287 | Calpain inhibitor | 0.267 0.051 DBMET03357 | ||
| 0.246 | 0.005 | 0.246 | Acetylcholine M3 receptor antagonist | 0.182 0.008 DBMET03357 | ||
| 0.224 | 0.002 | 0.224 | Beta 3 adrenoreceptor agonist | 0.112 0.003 DBMET03357 | ||
| 0.258 | 0.039 | 0.264 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.264 0.037 DBMET03357 | DBMET03357 | |
| 0.278 | 0.059 | 0.359 | Antiamyloidogenic | 0.359 0.037 DBMET03357 | DBMET03357 | |
| 0.22 | 0.008 | 0.22 | Creatine kinase inhibitor | 0.124 0.038 DBMET03357 | ||
| 0.218 | 0.035 | 0.258 | Melanin inhibitor | 0.258 0.027 DBMET03357 | DBMET03357 | |
| 0.199 | 0.016 | 0.199 | Carbonic anhydrase III inhibitor | 0.18 0.02 DBMET03357 | ||
| 0.217 | 0.038 | 0.235 | Amylase inhibitor | 0.235 0.032 DBMET03357 | DBMET03357 | |
| 0.209 | 0.031 | 0.226 | Monophenol monooxygenase inhibitor | 0.226 0.027 DBMET03357 | DBMET03357 | |
| 0.246 | 0.069 | 0.246 | DNA synthesis inhibitor | 0.208 0.111 DBMET03357 | ||
| 0.188 | 0.012 | 0.211 | Sphingomyelinase inhibitor | 0.211 0.008 DBMET03357 | DBMET03357 | |
| 0.186 | 0.012 | 0.186 | Aminoacyl-tRNA synthetase inhibitor | 0.152 0.018 DBMET03357 | ||
| 0.201 | 0.032 | 0.201 | Hemostatic | 0.175 0.045 DBMET03357 | ||
| 0.172 | 0.009 | 0.172 | Somatostatin 1 agonist | 0.137 0.017 DBMET03357 | ||
| 0.166 | 0.01 | 0.166 | Carbonic anhydrase stimulant | 0.124 0.014 DBMET03357 | ||
| 0.233 | 0.076 | 0.233 | Hypolipemic | 0.184 0.107 DBMET03357 | ||
| 0.199 | 0.045 | 0.199 | Phospholipase C inhibitor | 0.162 0.084 DBMET03357 | ||
| 0.165 | 0.011 | 0.165 | Anabolic | 0.139 0.024 DBMET03357 | ||
| 0.188 | 0.035 | 0.188 | Cell wall synthesis inhibitor | 0.128 0.088 DBMET03357 | ||
| 0.176 | 0.023 | 0.176 | Carbonic anhydrase XV inhibitor | 0.169 0.025 DBMET03357 | ||
| 0.265 | 0.113 | 0.269 | Apoptosis antagonist | 0.269 0.109 DBMET03357 | DBMET03357 | |
| 0.292 | 0.142 | 0.292 | Antibacterial | 0.238 0.188 DBMET03357 | ||
| 0.178 | 0.033 | 0.178 | Nav1.3 sodium channel blocker | 0.15 0.047 DBMET03357 | ||
| 0.208 | 0.069 | 0.208 | Neurotrophic factor enhancer | 0.193 0.083 DBMET03357 | ||
| 0.235 | 0.098 | 0.235 | Gastrin inhibitor | 0.195 0.157 DBMET03357 | ||
| 0.174 | 0.037 | 0.197 | Toll-Like receptor 2 antagonist | 0.197 0.025 DBMET03357 | DBMET03357 | |
| 0.171 | 0.035 | 0.182 | Cholesterol synthesis inhibitor | 0.182 0.031 DBMET03357 | DBMET03357 | |
| 0.153 | 0.019 | 0.184 | Electron transport complex I inhibitor | 0.184 0.01 DBMET03357 | DBMET03357 | |
| 0.168 | 0.035 | 0.176 | Cyclooxygenase 3 inhibitor | 0.176 0.03 DBMET03357 | DBMET03357 | |
| 0.167 | 0.037 | 0.167 | Interleukin 4 antagonist | 0.163 0.039 DBMET03357 | ||
| 0.155 | 0.026 | 0.155 | Mediator release inhibitor | 0.148 0.029 DBMET03357 | ||
| 0.237 | 0.109 | 0.237 | Insulysin inhibitor | 0.203 0.152 DBMET03357 | ||
| 0.188 | 0.06 | 0.188 | Succinate dehydrogenase inhibitor | 0.186 0.061 DBMET03357 | ||
| 0.132 | 0.008 | 0.132 | Alpha 2 adrenoreceptor agonist | 0.106 0.013 DBMET03357 | ||
| 0.265 | 0.141 | 0.265 | GABA C receptor rho-3 antagonist | |||
| 0.134 | 0.011 | 0.163 | Alpha 1 adrenoreceptor agonist | 0.163 0.008 DBMET03357 | DBMET03357 | |
| 0.182 | 0.061 | 0.182 | Thrombolytic | 0.152 0.08 DBMET03357 | ||
| 0.169 | 0.056 | 0.17 | Lipid peroxidase inhibitor | 0.17 0.055 DBMET03357 | DBMET03357 | |
| 0.142 | 0.029 | 0.142 | HIV-1 integrase (Overall Integration) inhibitor | 0.089 0.066 DBMET03357 | ||
| 0.194 | 0.081 | 0.261 | Amyloid beta aggregation inhibitor | 0.261 0.054 DBMET03357 | DBMET03357 | |
| 0.14 | 0.032 | 0.14 | Transcription factor STAT6 inhibitor | 0.11 0.08 DBMET03357 | ||
| 0.144 | 0.037 | 0.144 | Chelator | 0.125 0.049 DBMET03357 | ||
| 0.127 | 0.021 | 0.127 | Ornithine decarboxylase inhibitor | 0.116 0.029 DBMET03357 | ||
| 0.173 | 0.067 | 0.176 | ATPase inhibitor | 0.176 0.063 DBMET03357 | DBMET03357 | |
| 0.135 | 0.031 | 0.135 | DOPA decarboxylase inhibitor | 0.105 0.066 DBMET03357 | ||
| 0.186 | 0.082 | 0.186 | Anesthetic general | 0.178 0.088 DBMET03357 | ||
| 0.15 | 0.046 | 0.15 | Proteasome inhibitor | 0.132 0.057 DBMET03357 | ||
| 0.146 | 0.043 | 0.17 | Vanilloid 1 agonist | 0.17 0.023 DBMET03357 | DBMET03357 | |
| 0.127 | 0.024 | 0.127 | Histidine decarboxylase inhibitor | 0.092 0.035 DBMET03357 | ||
| 0.227 | 0.124 | 0.267 | 12-Lipoxygenase inhibitor | 0.267 0.099 DBMET03357 | DBMET03357 | |
| 0.179 | 0.077 | 0.196 | Nitric oxide antagonist | 0.196 0.069 DBMET03357 | DBMET03357 | |
| 0.118 | 0.017 | 0.118 | Acetylcholine M2 receptor antagonist | 0.086 0.026 DBMET03357 | ||
| 0.111 | 0.013 | 0.111 | Maillard reaction inhibitor | 0.095 0.019 DBMET03357 | ||
| 0.146 | 0.048 | 0.154 | Alkylator | 0.154 0.045 DBMET03357 | DBMET03357 | |
| 0.154 | 0.056 | 0.154 | Neurotrophic factor | 0.147 0.062 DBMET03357 | ||
| 0.147 | 0.051 | 0.147 | Ca2+-transporting ATPase inhibitor | 0.134 0.098 DBMET03357 | ||
| 0.139 | 0.043 | 0.139 | Aminopeptidase B inhibitor | |||
| 0.139 | 0.044 | 0.172 | Alpha 2b adrenoreceptor antagonist | 0.172 0.031 DBMET03357 | DBMET03357 | |
| 0.107 | 0.012 | 0.107 | GABA B receptor agonist | 0.105 0.013 DBMET03357 | ||
| 0.125 | 0.032 | 0.125 | Catalase inhibitor | 0.093 0.041 DBMET03357 | ||
| 0.118 | 0.03 | 0.118 | NADH dehydrogenase inhibitor | 0.087 0.061 DBMET03357 | ||
| 0.123 | 0.035 | 0.158 | Alpha 2 adrenoreceptor antagonist | 0.158 0.025 DBMET03357 | DBMET03357 | |
| 0.188 | 0.101 | 0.188 | Angiogenesis stimulant | 0.184 0.103 DBMET03357 | ||
| 0.104 | 0.017 | 0.104 | Acetylcholine M5 receptor antagonist | 0.069 0.031 DBMET03357 | ||
| 0.135 | 0.048 | 0.135 | Cystathionine beta-synthase inhibitor | 0.116 0.061 DBMET03357 | ||
| 0.11 | 0.024 | 0.132 | Granulocyte macrophage colony stimulating factor agonist | 0.132 0.01 DBMET03357 | DBMET03357 | |
| 0.109 | 0.023 | 0.109 | Aminopeptidase I inhibitor | |||
| 0.129 | 0.044 | 0.129 | GABA C receptor agonist | |||
| 0.117 | 0.033 | 0.132 | Glutamate (mGluR7) agonist | 0.132 0.02 DBMET03357 | DBMET03357 | |
| 0.239 | 0.157 | 0.239 | Immunosuppressant | 0.228 0.168 DBMET03357 | ||
| 0.103 | 0.021 | 0.103 | Estrogen-related receptor beta agonist | 0.098 0.027 DBMET03357 | ||
| 0.145 | 0.063 | 0.145 | Pregnane X receptor agonist | 0.126 0.111 DBMET03357 | ||
| 0.131 | 0.05 | 0.144 | Microtubule formation inhibitor | 0.144 0.041 DBMET03357 | DBMET03357 | |
| 0.16 | 0.079 | 0.164 | Neurotensin receptor agonist | 0.164 0.071 DBMET03357 | DBMET03357 | |
| 0.086 | 0.005 | 0.086 | Alpha 1d adrenoreceptor agonist | 0.06 0.011 DBMET03357 | ||
| 0.111 | 0.03 | 0.111 | Glutamate release inhibitor | 0.104 0.037 DBMET03357 | ||
| 0.154 | 0.073 | 0.154 | Interferon gamma antagonist | 0.147 0.082 DBMET03357 | ||
| 0.119 | 0.039 | 0.119 | Factor V inhibitor | 0.111 0.05 DBMET03357 | ||
| 0.097 | 0.017 | 0.097 | Neuraminidase (influenza) inhibitor | 0.079 0.026 DBMET03357 | ||
| 0.126 | 0.047 | 0.126 | Nav1.4 sodium channel blocker | 0.103 0.072 DBMET03357 | ||
| 0.121 | 0.044 | 0.121 | Urease inhibitor | 0.119 0.045 DBMET03357 | ||
| 0.079 | 0.008 | 0.079 | Alpha 1b adrenoreceptor agonist | 0.075 0.009 DBMET03357 | ||
| 0.104 | 0.035 | 0.136 | Alpha 2a adrenoreceptor antagonist | 0.136 0.025 DBMET03357 | DBMET03357 | |
| 0.088 | 0.02 | 0.088 | Neuraminidase inhibitor | 0.074 0.03 DBMET03357 | ||
| 0.121 | 0.053 | 0.121 | Ferrochelatase inhibitor | |||
| 0.073 | 0.006 | 0.073 | Diamine oxidase inhibitor | 0.068 0.007 DBMET03357 | ||
| 0.141 | 0.075 | 0.149 | Protein kinase stimulant | 0.149 0.069 DBMET03357 | DBMET03357 | |
| 0.11 | 0.046 | 0.11 | Prolactin inhibitor | |||
| 0.077 | 0.014 | 0.077 | Myc inhibitor | 0.067 0.022 DBMET03357 | ||
| 0.089 | 0.026 | 0.089 | Secretase beta inhibitor | 0.075 0.043 DBMET03357 | ||
| 0.187 | 0.127 | 0.219 | DNA damaging | 0.219 0.101 DBMET03357 | DBMET03357 | |
| 0.099 | 0.04 | 0.099 | Carbonic anhydrase VI inhibitor | 0.098 0.04 DBMET03357 | ||
| 0.062 | 0.004 | 0.062 | Alpha 2a adrenoreceptor agonist | 0.025 0.006 DBMET03357 | ||
| 0.142 | 0.083 | 0.142 | Insulin secretagoues | 0.121 0.11 DBMET03357 | ||
| 0.098 | 0.039 | 0.098 | Glutathione S-transferase inhibitor | 0.079 0.062 DBMET03357 | ||
| 0.141 | 0.084 | 0.141 | Phospholipase A2 inhibitor | 0.123 0.113 DBMET03357 | ||
| 0.11 | 0.053 | 0.11 | Adenylate kinase inhibitor | |||
| 0.105 | 0.049 | 0.105 | Lanosterol 14 alpha demethylase inhibitor | |||
| 0.065 | 0.01 | 0.065 | Dopamine D5 agonist | 0.04 0.027 DBMET03357 | ||
| 0.084 | 0.029 | 0.084 | Phospholipase D inhibitor | |||
| 0.071 | 0.016 | 0.071 | Alpha-mannosidase inhibitor | 0.059 0.028 DBMET03357 | ||
| 0.094 | 0.04 | 0.106 | Vanilloid agonist | 0.106 0.027 DBMET03357 | DBMET03357 | |
| 0.126 | 0.072 | 0.13 | Antibacterial (Helicobacter pylori) | 0.13 0.067 DBMET03357 | DBMET03357 | |
| 0.107 | 0.054 | 0.107 | UDP-glucose 4-epimerase inhibitor | |||
| 0.129 | 0.076 | 0.129 | Sphingosine 1-phosphate receptor 2 antagonist | |||
| 0.153 | 0.101 | 0.23 | DNA methyltransferase I inhibitor | 0.23 0.055 DBMET03357 | DBMET03357 | |
| 0.059 | 0.007 | 0.059 | Lysophosphatidic acid 2 receptor antagonist | 0.051 0.008 DBMET03357 | ||
| 0.182 | 0.129 | 0.182 | RNA-directed DNA polymerase inhibitor | 0.165 0.163 DBMET03357 | ||
| 0.1 | 0.05 | 0.115 | Toll-Like receptor 3 antagonist | 0.115 0.033 DBMET03357 | DBMET03357 | |
| 0.054 | 0.005 | 0.054 | Alpha 1a adrenoreceptor agonist | 0.046 0.005 DBMET03357 | ||
| 0.145 | 0.095 | 0.145 | Arachidonic acid antagonist | |||
| 0.101 | 0.051 | 0.101 | Phosphodiesterase 6D inhibitor | 0.09 0.077 DBMET03357 | ||
| 0.159 | 0.11 | 0.225 | DNA methylase inhibitor | 0.225 0.063 DBMET03357 | DBMET03357 | |
| 0.099 | 0.051 | 0.099 | Bile acid receptor antagonist | 0.09 0.075 DBMET03357 | ||
| 0.092 | 0.044 | 0.092 | Histamine H2 receptor antagonist | |||
| 0.064 | 0.018 | 0.072 | Vanilloid 2 antagonist | 0.072 0.013 DBMET03357 | DBMET03357 | |
| 0.105 | 0.06 | 0.106 | Gastric antisecretory | 0.106 0.058 DBMET03357 | DBMET03357 | |
| 0.255 | 0.209 | 0.34 | Apoptosis agonist | 0.34 0.145 DBMET03357 | DBMET03357 | |
| 0.061 | 0.016 | 0.061 | Mannosidase inhibitor | 0.045 0.031 DBMET03357 | ||
| 0.085 | 0.041 | 0.085 | Glutamate dehydrogenase inhibitor | |||
| 0.154 | 0.112 | 0.2 | P-glycoprotein inhibitor | 0.2 0.064 DBMET03357 | DBMET03357 | |
| 0.057 | 0.015 | 0.057 | Neuraminidase (Influenza A) inhibitor | 0.051 0.023 DBMET03357 | ||
| 0.187 | 0.146 | 0.187 | Neuropeptide Y2 antagonist | |||
| 0.065 | 0.026 | 0.065 | Sphingosine kinase 2 inhibitor | |||
| 0.171 | 0.133 | 0.171 | 5 Hydroxytryptamine 3E antagonist | |||
| 0.083 | 0.045 | 0.086 | Keratolytic | 0.086 0.042 DBMET03357 | DBMET03357 | |
| 0.093 | 0.056 | 0.093 | Triose-phosphate isomerase inhibitor | |||
| 0.069 | 0.033 | 0.069 | Purinergic P2X1 antagonist | |||
| 0.096 | 0.06 | 0.15 | Alpha adrenoreceptor antagonist | 0.15 0.038 DBMET03357 | DBMET03357 | |
| 0.083 | 0.048 | 0.083 | Na+ K+ transporting ATPase inhibitor | |||
| 0.067 | 0.032 | 0.067 | Cathepsin E inhibitor | 0.062 0.038 DBMET03357 | ||
| 0.054 | 0.021 | 0.054 | Oxytocin agonist | |||
| 0.038 | 0.005 | 0.038 | Calcium-sensing receptor antagonist | 0.027 0.007 DBMET03357 | ||
| 0.044 | 0.011 | 0.044 | Catechol O-methyltransferase inhibitor | 0.035 0.019 DBMET03357 | ||
| 0.109 | 0.077 | 0.109 | DNA polymerase I inhibitor | 0.101 0.085 DBMET03357 | ||
| 0.044 | 0.012 | 0.044 | Ceramide glucosyltransferase inhibitor | |||
| 0.109 | 0.077 | 0.109 | Caspase 3 inhibitor | |||
| 0.098 | 0.068 | 0.123 | Alpha 2c adrenoreceptor antagonist | 0.123 0.047 DBMET03357 | DBMET03357 | |
| 0.088 | 0.057 | 0.131 | Calcium antagonist | 0.131 0.029 DBMET03357 | DBMET03357 | |
| 0.128 | 0.099 | 0.128 | Thiol protease inhibitor | |||
| 0.117 | 0.089 | 0.117 | Papain-like protease (SARS coronavirus) inhibitor | 0.117 0.089 DBMET03357 | ||
| 0.092 | 0.063 | 0.092 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | |||
| 0.056 | 0.028 | 0.056 | Lysophosphatidic acid 3 receptor antagonist | 0.048 0.039 DBMET03357 | ||
| 0.06 | 0.034 | 0.06 | Ribonucleoside-diphosphate reductase inhibitor | |||
| 0.034 | 0.008 | 0.034 | 1,3-Beta-glucan synthase inhibitor | 0.03 0.014 DBMET03357 | ||
| 0.061 | 0.036 | 0.061 | Ribonucleotide reductase inhibitor | |||
| 0.07 | 0.044 | 0.07 | Dopamine agonist | |||
| 0.133 | 0.107 | 0.133 | Heat shock protein 70 antagonist | 0.132 0.11 DBMET03357 | ||
| 0.062 | 0.036 | 0.062 | Sphingosine kinase inhibitor | |||
| 0.06 | 0.036 | 0.06 | Alcohol oxidase inhibitor | |||
| 0.028 | 0.005 | 0.028 | Neuraminidase (Influenza B) inhibitor | 0.021 0.014 DBMET03357 | ||
| 0.053 | 0.03 | 0.053 | Potassium channel (Inward rectifier) blocker | |||
| 0.046 | 0.023 | 0.046 | Somatostatin 1 antagonist | |||
| 0.13 | 0.107 | 0.13 | Growth hormone agonist | |||
| 0.061 | 0.039 | 0.061 | Heat shock protein 90 beta antagonist | 0.059 0.041 DBMET03357 | ||
| 0.058 | 0.036 | 0.058 | Acetyl-CoA transferase 2 inhibitor | 0.055 0.042 DBMET03357 | ||
| 0.041 | 0.019 | 0.046 | Phosphoglycerate kinase inhibitor | 0.046 0.016 DBMET03357 | DBMET03357 | |
| 0.077 | 0.056 | 0.077 | MAP kinase kinase 7 inhibitor | |||
| 0.058 | 0.038 | 0.058 | Argininosuccinate synthase inhibitor | |||
| 0.139 | 0.121 | 0.161 | Hepatoprotectant | 0.161 0.098 DBMET03357 | DBMET03357 | |
| 0.053 | 0.037 | 0.053 | Ornithine carbamoyltransferase inhibitor | |||
| 0.084 | 0.068 | 0.098 | ATPase (Vacuolar H+) inhibitor | 0.098 0.042 DBMET03357 | DBMET03357 | |
| 0.042 | 0.027 | 0.042 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | |||
| 0.023 | 0.007 | 0.025 | Ileal bile acid transport inhibitor | 0.025 0.006 DBMET03357 | DBMET03357 | |
| 0.051 | 0.036 | 0.051 | Factor IXa inhibitor | |||
| 0.06 | 0.047 | 0.06 | NMDA receptor agonist | |||
| 0.044 | 0.031 | 0.044 | Geranyltranstransferase inhibitor | |||
| 0.053 | 0.039 | 0.053 | Cathepsin D inhibitor | |||
| 0.022 | 0.008 | 0.022 | Antibiotic Anthracycline-like | 0.022 0.007 DBMET03357 | ||
| 0.03 | 0.017 | 0.03 | Purinergic P2Y15 antagonist | |||
| 0.1 | 0.088 | 0.1 | Photosensitizer | 0.097 0.096 DBMET03357 | ||
| 0.072 | 0.059 | 0.072 | GABA aminotransferase inhibitor | |||
| 0.18 | 0.168 | 0.18 | Transcription factor STAT inhibitor | |||
| 0.173 | 0.162 | 0.173 | 5 Hydroxytryptamine 1E antagonist | 0.171 0.165 DBMET03357 | ||
| 0.037 | 0.025 | 0.037 | Arginase inhibitor | |||
| 0.053 | 0.042 | 0.053 | Glucosylceramidase inhibitor | |||
| 0.057 | 0.045 | 0.057 | Androgen agonist | |||
| 0.056 | 0.044 | 0.056 | Botulinum neurotoxin type A inhibitor | |||
| 0.068 | 0.057 | 0.068 | Cathepsin G inhibitor | |||
| 0.069 | 0.059 | 0.087 | Carbonic anhydrase XIII inhibitor | 0.087 0.045 DBMET03357 | DBMET03357 | |
| 0.079 | 0.07 | 0.079 | D-Ala-D-Ala ligase inhibitor | |||
| 0.056 | 0.047 | 0.056 | Carbamoyl phosphate synthetase inhibitor | |||
| 0.071 | 0.062 | 0.071 | Vanilloid 4 agonist | |||
| 0.058 | 0.05 | 0.058 | HIV-1 integrase (3'-Processing) inhibitor | |||
| 0.067 | 0.059 | 0.067 | Porphobilinogen synthase inhibitor | |||
| 0.025 | 0.017 | 0.025 | Lysophosphatidic acid receptor 1 agonist | |||
| 0.21 | 0.202 | 0.228 | 15-Lipoxygenase inhibitor | 0.228 0.184 DBMET03357 | DBMET03357 | |
| 0.089 | 0.082 | 0.089 | Falcipain 3 inhibitor | |||
| 0.051 | 0.043 | 0.051 | Leukotriene B4 antagonist | 0.051 0.041 DBMET03357 | ||
| 0.019 | 0.012 | 0.019 | Alpha 2b adrenoreceptor agonist | |||
| 0.019 | 0.012 | 0.019 | Estrogen-related receptor gamma agonist | |||
| 0.088 | 0.081 | 0.088 | Nitric-oxide synthase inhibitor | |||
| 0.06 | 0.054 | 0.06 | Interferon inducer | |||
| 0.054 | 0.048 | 0.054 | Sphingosine 1-phosphate receptor 3 antagonist | |||
| 0.057 | 0.052 | 0.057 | Selectin antagonist | |||
| 0.072 | 0.067 | 0.072 | Interferon agonist | |||
| 0.051 | 0.046 | 0.051 | Cathepsin B inhibitor | |||
| 0.078 | 0.073 | 0.078 | Transcription factor NF kappa B stimulant | |||
| 0.064 | 0.06 | 0.064 | HIV-1 integrase inhibitor | |||
| 0.093 | 0.089 | 0.093 | GABA C receptor antagonist | |||
| 0.024 | 0.02 | 0.024 | Vanilloid 2 agonist | |||
| 0.055 | 0.052 | 0.055 | NMDA 2C receptor antagonist | |||
| 0.038 | 0.035 | 0.038 | Sphingosine kinase 1 inhibitor | |||
| 0.038 | 0.035 | 0.04 | Plasmepsin II inhibitor | 0.04 0.03 DBMET03357 | DBMET03357 | |
| 0.07 | 0.068 | 0.07 | Acetylcholine nicotinic antagonist | |||
| 0.076 | 0.074 | 0.077 | Myeloperoxidase inhibitor | 0.077 0.073 DBMET03357 | DBMET03357 | |
| 0.027 | 0.025 | 0.027 | Plasmepsin I inhibitor | |||
| 0.05 | 0.049 | 0.05 | Epithelial sodium channel blocker | |||
| 0.046 | 0.047 | 0.05 | Factor III inhibitor | 0.05 0.035 DBMET03357 | DBMET03357 | |
| 0.045 | 0.05 | 0.057 | Glucose-6-phosphate translocase inhibitor | 0.057 0.028 DBMET03357 | DBMET03357 | |
| 0.17 | 0.176 | 0.194 | Lipoxygenase inhibitor | 0.194 0.146 DBMET03357 | DBMET03357 | |
| 0.049 | 0.072 | 0.077 | Alpha 1b adrenoreceptor antagonist | 0.077 0.048 DBMET03357 | DBMET03357 | |
| 0.036 | 0.081 | 0.076 | Purinergic P2X2 antagonist | 0.076 0.042 DBMET03357 | DBMET03357 | |
| 0.079 | 0.124 | 0.096 | Beta amyloid protein antagonist | 0.096 0.095 DBMET03357 | DBMET03357 | |
| 0.029 | 0.078 | 0.05 | Alpha 1d adrenoreceptor antagonist | 0.05 0.049 DBMET03357 | DBMET03357 | |
| 0.04 | 0.095 | 0.069 | Alpha 1 adrenoreceptor antagonist | 0.069 0.06 DBMET03357 | DBMET03357 | |
| 0.027 | 0.093 | 0.058 | Alpha tubulin antagonist | 0.058 0.032 DBMET03357 | DBMET03357 | |
| 0.023 | 0.095 | 0.08 | Beta tubulin antagonist | 0.08 0.03 DBMET03357 | DBMET03357 | |
| 0.152 | 0.268 | 0.231 | Caspase 3 stimulant | 0.231 0.13 DBMET03357 | DBMET03357 | |
| 0.093 | 0.211 | 0.231 | Antimitotic | 0.231 0.068 DBMET03357 | DBMET03357 | |
| 0.051 | 0.193 | 0.173 | Tubulin antagonist | 0.173 0.048 DBMET03357 | DBMET03357 | |
| 0.029 | 0.185 | 0.086 | Phosphodiesterase IV inhibitor | 0.086 0.056 DBMET03357 | DBMET03357 | |
| 0.09 | 0.258 | 0.202 | Tumour necrosis factor alpha release inhibitor | 0.202 0.107 DBMET03357 | DBMET03357 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |